Article Versions Notes

Sterenczak KA, Fuellen G, Jünemann A, Guthoff RF, Stachs O, Stahnke T. The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery? Pharmaceutics. 2023; 15(2):329. https://doi.org/10.3390/pharmaceutics15020329

Sterenczak, Katharina A., Georg Fuellen, Anselm Jünemann, Rudolf F. Guthoff, Oliver Stachs, and Thomas Stahnke. 2023. "The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?" Pharmaceutics 15, no. 2: 329. https://doi.org/10.3390/pharmaceutics15020329

Sterenczak, K. A., Fuellen, G., Jünemann, A., Guthoff, R. F., Stachs, O., & Stahnke, T. (2023). The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery? Pharmaceutics, 15(2), 329. https://doi.org/10.3390/pharmaceutics15020329